Full-Time

Director of Business Development

Salvo Health

Salvo Health

51-200 employees

Subscription-based digital health for fatty liver

Compensation Overview

$125k - $250k/yr

+ Sales commissions/bonuses target + Equity grant

Jersey City, NJ, USA

Remote

Remote within the Midwest, East, or Southeast is preferred.

Category
Business & Strategy (1)
Required Skills
Forecasting

Get referred to Salvo Health

See people who can refer or advise you

Requirements
  • 7-10 years of experience in business development, partnerships, or strategic sales in healthcare, with meaningful experience working inside or selling into health systems.
  • Deep familiarity with health system decision-making, including budget cycles, clinical operations, value-based care priorities, and service line versus central administration roles.
  • A track record of owning and closing deals, carrying a quota or equivalent accountability, and reporting pipeline metrics.
  • Understanding of the health system and private-equity-backed medical service organization landscape, including organizational structures, decision-making, and buy-versus-build-versus-partner choices.
  • An active network in the Midwest, East, or Southeast.
  • Ability to operate with startup speed, compress timelines, create momentum, and close independently.
  • Strong executive presence and communication skills, including presenting to C-suite audiences and adapting messaging for practice administrators.
  • Comfort with ambiguity and a builder's mentality.
Responsibilities
  • Build and own Salvo's health system go-to-market motion by defining the target account list, entry strategy, and partnership frameworks.
  • Identify and cultivate relationships with economic buyers inside health systems, including service line leaders, chief medical officers, ambulatory executives, and population health executives.
  • Navigate complex, multi-stakeholder contracting processes and translate Salvo's value proposition into system-friendly language covering quality, access, and total cost of care.
  • Collaborate with clinical, product, and operations teams to structure health system partnerships for long-term success.
  • Develop and refine materials, case studies, and return-on-investment models for health system audiences.
  • Grow and close new gastrointestinal medical service organization partnerships.
  • Map the economic buyer landscape in private-equity-backed medical service organization structures and align incentives across practice administrators, physician partners, and private equity sponsors.
  • Manage a disciplined pipeline with accurate forecasting, deal-stage hygiene, and consistent velocity.
  • Drive deal cycles while maintaining the relationship depth required for gastrointestinal medical service organization partnerships.
  • Represent Salvo at gastrointestinal-specific industry events and networks, including DHPA, AGA, and DDW, to build brand awareness and source deals.
  • Partner with marketing, clinical, and product teams to refine positioning, develop materials, and respond to requests for proposals.
  • Provide market intelligence on health system trends, competitive dynamics, and partnership models to executive leadership.
  • Help define the business development team structure and contribute to hiring and onboarding future business development talent.
Desired Qualifications
  • Experience with gastrointestinal care, specialty care, ambulatory care, or adjacent service lines.
  • Familiarity with health system or private-equity-backed medical service organization partnerships.

Salvo Health provides digital health services for metabolic liver diseases, mainly fatty liver disease. It runs a remote patient monitoring (RPM) platform that lets patients with conditions like MASLD and MASH stay connected with their care team via text, enabling real-time health management without frequent in-person visits. The service is delivered through a subscription model that includes personalized care plans and continuous access to clinicians, with potential reimbursements or partnership fees from payers and practices. How it differs from competitors is its focus on real-time, text-based communication and ongoing, personalized care for chronic liver and gut conditions via RPM, rather than one-off visits or generic digital programs. The company’s goal is to improve patient outcomes and satisfaction by making specialized liver-care more accessible, timely, and tailored to each patient’s needs.

Company Size

51-200

Company Stage

Series A

Total Funding

$28M

Headquarters

New York City, New York

Founded

2021

Get referred to Salvo Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • January 2026 revenue grew 800%, proving strong clinic demand and retention.
  • March 2026 Lohman expansion extends FDA-cleared home monitoring into six new states.
  • Salvo's MASH and MASLD RPM aligns with GLP-1-driven fatty-liver treatment demand.

What critics are saying

  • Cylinder, Oshi, and Ayble crowd virtual GI; Salvo lacks durable exclusivity.
  • Revenue depends on independent GI adoption; January 2026 expansion still requires clinic integration.
  • HHS reimbursement and RPM policy shifts can crush unit economics by 2027.

What makes Salvo Health unique

  • Salvo integrates gastroenterologists, dietitians, nurses, and behavioral health into one workflow.
  • January 2026 Series A reached $8.5 million from ManchesterStory, City Light, and Threshold.
  • Salvo signed 801 gastroenterologists, covering 16% of independent U.S. GI practices.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Remote Work Options

Flexible Work Hours

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-2%

2 year growth

-1%
HIT Consultant
Feb 4th, 2026
Salvo Health raises $8.5M to support independent GI practices with AI-powered care platform

Salvo Health has raised $8.5 million in a Series A round led by ManchesterStory, City Light Capital and Threshold Ventures, following 800% revenue growth last year. The company provides wraparound support for independent gastroenterology practices rather than competing with them directly. The platform has signed 801 gastroenterologists, representing 16% of independent US practices. It offers patients access to registered dietitians, behavioural health specialists and nurses through AI-enabled continuous care that integrates with existing clinics. The hybrid model has delivered a 79% reduction in GI-related emergency room utilisation. Salvo addresses a fragmented market serving 100 million Americans with gastrointestinal issues, providing ongoing support for diet, stress management and medication adherence that independent practices typically cannot staff full-time.

FinSMEs
Jan 26th, 2026
Salvo Health Raises $8.5M in Series A Funding

Salvo Health raises $8.5M in Series A funding. Salvo Health, a New York-based provider of a virtual care platform specializing in gastrointestinal and metabolic health, raised $8.5m in Series A funding. The round was co-led by ManchesterStory, City Light Capital, and Threshold Ventures, with participation from new investors The Artemis Fund, Contour Venture Partners, Owl Capital, and Impact X Capital Partners, and existing investors Human Ventures, Torch Capital, Felicis Ventures, and Alumni Ventures. The company intends to use the funds to expand its engineering team for an AI-led roadmap and increase the national hiring of registered dietitians, behavioral health professionals, and nurses to meet rising patient demand. Led by CEO Jeffrey Glueck, COO Marin Rothenberg, and CMO Dr. Erin Hendriks, Salvo Health provides brick & mortar clinics with a continuous care platform that enables users to save time, increase revenue, and improve patient outcomes by offering direct access to a gut-focused care team. In 2025, the company has grown patients and revenue by 800% YoY and enterprise agreements with GI doctors by more than 1,000%. Salvo has also signed agreements with 801 GIs.

HIStalk Practice
Jun 9th, 2025
Home " News " Currently Reading:

Salvo Health announces $4 million in new funding.

MobiHealthNews
Jun 5th, 2025
Salvo Health raises $4M for expansion

Salvo Health raised $4M in an extended Seed Prime round, following a $5M investment last year. The funds will expand its clinical team and virtual care platform across GI partner clinics with 700 physicians. The company, which launched in 2022 with $10.5M funding, has seen an 800% rise in patient volume and aims to grow revenue sixfold by year-end. New investor The Artemis Fund joined existing investors in this round.

Alumni Ventures
Sep 23rd, 2024
Alumni Ventures Invests in Salvo Health to Revolutionize Chronic Condition Management

Alumni Ventures invests in Salvo Health to revolutionize chronic condition management.